MapLight Therapeutics Stock Forecast - Relative Strength Index
| MPLT Stock | 17.57 0.36 2.01% |
MapLight Stock Forecast is based on your current time horizon.
At this time the rsi of MapLight Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using MapLight Therapeutics hype-based prediction, you can estimate the value of MapLight Therapeutics Common from the perspective of MapLight Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
MapLight Therapeutics Hype to Price Pattern
Investor biases related to MapLight Therapeutics' public news can be used to forecast risks associated with an investment in MapLight. The trend in average sentiment can be used to explain how an investor holding MapLight can time the market purely based on public headlines and social activities around MapLight Therapeutics Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MapLight Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about MapLight Therapeutics.
MapLight Therapeutics after-hype prediction price | USD 17.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of MapLight Therapeutics to cross-verify your projections. MapLight Therapeutics Additional Predictive Modules
Most predictive techniques to examine MapLight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MapLight using various technical indicators. When you analyze MapLight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check MapLight Therapeutics Volatility | Backtest MapLight Therapeutics | Information Ratio |
MapLight Therapeutics Trading Date Momentum
| On January 02 2026 MapLight Therapeutics Common was traded for 17.57 at the closing time. The top price for the day was 18.25 and the lowest listed price was 17.21 . There was no trading activity during the period 0.0. Lack of trading volume on January 2, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.88% . |
| Compare MapLight Therapeutics to competition |
Other Forecasting Options for MapLight Therapeutics
For every potential investor in MapLight, whether a beginner or expert, MapLight Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MapLight Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MapLight. Basic forecasting techniques help filter out the noise by identifying MapLight Therapeutics' price trends.MapLight Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MapLight Therapeutics stock to make a market-neutral strategy. Peer analysis of MapLight Therapeutics could also be used in its relative valuation, which is a method of valuing MapLight Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MapLight Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of MapLight Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of MapLight Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MapLight Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how MapLight Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MapLight Therapeutics shares will generate the highest return on investment. By undertsting and applying MapLight Therapeutics stock market strength indicators, traders can identify MapLight Therapeutics Common entry and exit signals to maximize returns.
MapLight Therapeutics Risk Indicators
The analysis of MapLight Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MapLight Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting maplight stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.06 | |||
| Semi Deviation | 4.17 | |||
| Standard Deviation | 6.48 | |||
| Variance | 41.96 | |||
| Downside Variance | 18.13 | |||
| Semi Variance | 17.38 | |||
| Expected Short fall | (5.59) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics' price analysis, check to measure MapLight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics is operating at the current time. Most of MapLight Therapeutics' value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics' price. Additionally, you may evaluate how the addition of MapLight Therapeutics to your portfolios can decrease your overall portfolio volatility.